#USA #Smithfield #ALCOR Scientific #ESR Test #iSED

Introduction

A recent peer-reviewed study highlights a significant advancement in laboratory testing technology with ALCOR Scientific's iSED® analyzers, which challenge the long-standing four-hour viability window for erythrocyte sedimentation rate (ESR) testing. This technological innovation promises to reshape lab operations and significantly enhance patient care, making it a breakthrough in the field of medicine.

Extended Sample Stability

Traditionally, ESR tests required samples to be analyzed within four hours. This narrow timeframe often posed logistical challenges for clinical laboratories, especially those reliant on courier systems for specimen transport. ALCOR's iSED® analyzers, however, offer an astounding increase in sample stability — remaining accurate for up to 28 hours at room temperature and even longer under refrigeration. This new flexibility allows labs to work efficiently without risking the integrity of their results.

The study conducted on the iSED® analyzers confirmed their capabilities to outperform the conventional Westergren method significantly, which had been the industry standard for decades. The ability to maintain sample accuracy for such an extended period offers a viable solution to common logistical obstacles faced by modern labs.

Implications for Clinical Labs

The ramifications of this technology are profound. Clinical laboratories often operate under high stress due to staffing shortages and the growing number of collection sites. The extended sample stability provided by the iSED® analyzers not only reduces the burden on couriers but also helps mitigate the chances of sample degradation during transit. This means that, for clinical labs, the burdensome task of adhering to strict testing windows is now a thing of the past.

1. Reliable Results: Laboratories can expect greater confidence in their results thanks to the stable conditions provided by the iSED® analyzers, especially for samples that might have experienced delays during transport.
2. Reduced Rejections: With longer sample viability, there are fewer rejections of delayed samples, leading to better patient outcomes and the possibility of testing specimens that previously would have been discarded due to timing issues.
3. Fewer Needle Sticks: Patients will benefit from having to undergo fewer blood draws, as one sample can now serve multiple testing purposes, which enhances the overall patient experience.

Modern Lab Workflows

The integration of iSED® analyzers into laboratory workflows marks a pivotal change. Given the growing complexity of laboratory logistics, these systems facilitate a more streamlined operation that can handle the demands of modern healthcare systems effectively. The iSED® technology allows for one tube to fulfill multiple tests, for example, for both ESR and CBC testing, ultimately economizing on resources while maintaining testing quality.

Jim Post, CEO of Alcor Scientific, emphasizes, "Extending room temperature stability by an additional 24 hours is a game changer, not only improving logistics but truly enhancing patient care by ensuring reliable results."

Study Overview

The full study, titled "Measuring Erythrocyte Sedimentation Rate Using Photometric Rheology Technology Demonstrates Superior Sample Stability as Compared to the Westergren Method," illustrates the independent validations performed and underscores the rigorous methodology employed in support of these findings. It was funded under an Institutional Review Board approved study at multiple hospital sites, thereby affirming the credibility of the research outcomes.

Conclusion

In conclusion, the advancements achieved through ALCOR Scientific's iSED® analyzers do not merely provide a technological upgrade; they signify a transformative step forward in laboratory medicine. With extended sample stability, enhanced patient care, and improved logistics, this technology redefines the standard of care in diagnostics, paving the way for a more efficient and effective healthcare environment. For more details, interested parties can explore the full study at Diagnostics.